Guest guest Posted April 27, 2001 Report Share Posted April 27, 2001 Vaccine research overlooked in AIDS pandemic ABUJA, Nigeria (AP) -- Developing a vaccine to prevent AIDS should be given top priority in the fight against the deadly virus sweeping Africa, a leading epidemiologist said. Efforts to develop a vaccine risked getting overlooked in the push to raise money to fight AIDS, said Seth Berkley, president of the New York-based International AIDS Vaccine Initiative. However, key decisions on whether to pursue vaccine " candidates " currently in human trials may need to be made as early as 2002, he said. Berkley spoke Friday on the sidelines of a two-day African AIDS summit hosted by Nigeria and the Organization of African Unity. On Friday, African leaders signed a declaration calling on members to aim at spending 15 percent of their national budgets on health programs, including a significant proportion on AIDS and to provide cheap and effective drugs to treat those infected. The Vaccine Initiative -- a private, nonprofit organization funded by governments, foundations and private enterprise -- has raised more than $300 million to assist vaccine research and create systems for distributing them in the developing world. Yet Berkley estimates that the project would require at least double that figure to give research bodies " a chance " of developing vaccines by 2007. U.N. Secretary-General Kofi n this week announced efforts to create a global " war chest " worth $7 billion to $10 billion to fight AIDS. It was unclear how much would be devoted to vaccine research. Other observers said vaccine trials could be " fast-tracked " in about half the time or less if funding in the billions was made available. Billions of dollars have gone into the development of effective AIDS treatments, but vaccine research has received relatively little funding. Pharmaceutical companies have viewed it as unprofitable, and most AIDS activists have focused their efforts on finding a cure. U.S. government funding of HIV-AIDS research last year topped $2 billion, with about $250 million going toward vaccine research. The rest went toward developing drugs to treat those with the disease. The Bill and Melinda Gates Foundation and Western countries such as Canada and the Netherlands have also provided millions of dollars of vaccine research funding. , head of the U.S. delegation to the African summit, said Friday that President Bush's administration would spend $2.5 billion on HIV-AIDS research this year, including $480 million for " international HIV/AIDS assistance. " She did not give a further breakdown. " The Bush administration is Africa's partner in this effort. The United States has been the world leader in research and assistance to battle these diseases, " said. Researching and testing an AIDS vaccine is only the first part of the problem, Berkley said. Getting it to those who need it most is another challenge. Vaccines developed for other diseases ordinarily take 15 years or more before they are affordable in poor countries. The Vaccine Initiative hopes that private firms involved in the production of the vaccines will offer them at cut-rate prices in poorer countries. " Extraordinarily complex planning is required, " Berkley said. " Establishing new production capacity alone normally requires four to five years. " http://www.canoe.ca/CNEWSTopNews/aids_apr28-ap.html Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 28, 2001 Report Share Posted April 28, 2001 I don't know much about how vaccines work, but I am correct in that most of them involve injecting a small amount of the virus/bacteria into the receipient, correct? So, in essence, if this aids vaccine goes through wouldn't people run the risk of contracting AIDS from the vaccine? Please tell me if I'm wrong. Vaccine research overlooked in AIDS Vaccine research overlooked in AIDS pandemic ABUJA, Nigeria (AP) -- Developing a vaccine to prevent AIDS should be given top priority in the fight against the deadly virus sweeping Africa, a leading epidemiologist said. Efforts to develop a vaccine risked getting overlooked in the push to raise money to fight AIDS, said Seth Berkley, president of the New York-based International AIDS Vaccine Initiative. However, key decisions on whether to pursue vaccine " candidates " currently in human trials may need to be made as early as 2002, he said. Berkley spoke Friday on the sidelines of a two-day African AIDS summit hosted by Nigeria and the Organization of African Unity. On Friday, African leaders signed a declaration calling on members to aim at spending 15 percent of their national budgets on health programs, including a significant proportion on AIDS and to provide cheap and effective drugs to treat those infected. The Vaccine Initiative -- a private, nonprofit organization funded by governments, foundations and private enterprise -- has raised more than $300 million to assist vaccine research and create systems for distributing them in the developing world. Yet Berkley estimates that the project would require at least double that figure to give research bodies " a chance " of developing vaccines by 2007. U.N. Secretary-General Kofi n this week announced efforts to create a global " war chest " worth $7 billion to $10 billion to fight AIDS. It was unclear how much would be devoted to vaccine research. Other observers said vaccine trials could be " fast-tracked " in about half the time or less if funding in the billions was made available. Billions of dollars have gone into the development of effective AIDS treatments, but vaccine research has received relatively little funding. Pharmaceutical companies have viewed it as unprofitable, and most AIDS activists have focused their efforts on finding a cure. U.S. government funding of HIV-AIDS research last year topped $2 billion, with about $250 million going toward vaccine research. The rest went toward developing drugs to treat those with the disease. The Bill and Melinda Gates Foundation and Western countries such as Canada and the Netherlands have also provided millions of dollars of vaccine research funding. , head of the U.S. delegation to the African summit, said Friday that President Bush's administration would spend $2.5 billion on HIV-AIDS research this year, including $480 million for " international HIV/AIDS assistance. " She did not give a further breakdown. " The Bush administration is Africa's partner in this effort. The United States has been the world leader in research and assistance to battle these diseases, " said. Researching and testing an AIDS vaccine is only the first part of the problem, Berkley said. Getting it to those who need it most is another challenge. Vaccines developed for other diseases ordinarily take 15 years or more before they are affordable in poor countries. The Vaccine Initiative hopes that private firms involved in the production of the vaccines will offer them at cut-rate prices in poorer countries. " Extraordinarily complex planning is required, " Berkley said. " Establishing new production capacity alone normally requires four to five years. " http://www.canoe.ca/CNEWSTopNews/aids_apr28-ap.html Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 28, 2001 Report Share Posted April 28, 2001 At 09:38 AM 04/28/2001 -0500, you wrote: >I don't know much about how vaccines work, but I am correct in that most of >them involve injecting a small amount of the virus/bacteria into the >receipient, correct? So, in essence, if this aids vaccine goes through >wouldn't people run the risk of contracting AIDS from the vaccine? Please >tell me if I'm wrong. Nope, exactly right. And you really need to know what causes aids to even try to make a vaccine and there is NO proof that HIV causes AIDS. Sometiems antibodies are present and sometimes not. You are all starting to see the lies you have been told http://www.nccn.net/~wwithin/links.htm#AIDS and http://www.aidsmyth.com Sheri -------------------------------------------------------- Sheri Nakken, R.N., MA moderator Vaccination Information & Choice Network, Nevada City CA & UK 530-478-1242 Voicemail in US http://www.nccn.net/~wwithin/vaccine.htm " All that is necessary for the triumph of evil is that good men ( & women) do nothing " ...Edmund Burke ANY INFO OBTAINED HERE NOT TO BE CONSTRUED AS MEDICAL OR LEGAL ADVICE. THE DECISION TO VACCINATE IS YOURS AND YOURS ALONE. Well Within's Earth Mysteries & Sacred Site Tours http://www.nccn.net/~wwithin International Tours, Homestudy Courses, ANTHRAX & OTHER Vaccine Dangers Education, Homeopathic Education CEU's for nurses, Books & Multi-Pure Water Filters Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 28, 2001 Report Share Posted April 28, 2001 Usually, when you get a vaccine, you test positive for antibodies against the virus (in theory). If an hiv vaccine is used, technically the recipient would test positive when given and hiv test.... so how will it be determined who needs to be put on azt? Maybe everyone? Wouldn't that be a cash cow - vaccinate at birth for hiv then you have an azt consumer for life.... S. Sheri Nakken wrote: > At 09:38 AM 04/28/2001 -0500, you wrote: > >I don't know much about how vaccines work, but I am correct in that > most of > >them involve injecting a small amount of the virus/bacteria into the > >receipient, correct? So, in essence, if this aids vaccine goes > through > >wouldn't people run the risk of contracting AIDS from the vaccine? > Please > >tell me if I'm wrong. > > Nope, exactly right. > And you really need to know what causes aids to even try to make a > vaccine > and there is NO proof that HIV causes AIDS. Sometiems antibodies are > present and sometimes not. > You are all starting to see the lies you have been told > http://www.nccn.net/~wwithin/links.htm#AIDS > and http://www.aidsmyth.com > > Sheri > -------------------------------------------------------- > Sheri Nakken, R.N., MA > moderator > Vaccination Information & Choice Network, Nevada City CA & UK > 530-478-1242 Voicemail in US > http://www.nccn.net/~wwithin/vaccine.htm > " All that is necessary for the triumph of evil is that good men > ( & > women) do nothing " ...Edmund Burke > ANY INFO OBTAINED HERE NOT TO BE CONSTRUED AS MEDICAL OR LEGAL ADVICE. > THE > DECISION TO VACCINATE IS YOURS AND YOURS ALONE. > Well Within's Earth Mysteries & Sacred Site Tours > http://www.nccn.net/~wwithin > International Tours, Homestudy Courses, ANTHRAX & OTHER Vaccine > Dangers > Education, Homeopathic Education > CEU's for nurses, Books & Multi-Pure Water Filters > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 28, 2001 Report Share Posted April 28, 2001 At 01:13 PM 04/28/2001 -0400, you wrote: >Usually, when you get a vaccine, you test positive for antibodies >against the virus (in theory). If an hiv vaccine is used, technically >the recipient would test positive when given and hiv test.... so how >will it be determined who needs to be put on azt? Maybe everyone? >Wouldn't that be a cash cow - vaccinate at birth for hiv then you have >an azt consumer for life.... >S. > Good point - we have such smart people on this list! -------------------------------------------------------- Sheri Nakken, R.N., MA moderator Vaccination Information & Choice Network, Nevada City CA & UK 530-478-1242 Voicemail in US http://www.nccn.net/~wwithin/vaccine.htm " All that is necessary for the triumph of evil is that good men ( & women) do nothing " ...Edmund Burke ANY INFO OBTAINED HERE NOT TO BE CONSTRUED AS MEDICAL OR LEGAL ADVICE. THE DECISION TO VACCINATE IS YOURS AND YOURS ALONE. Well Within's Earth Mysteries & Sacred Site Tours http://www.nccn.net/~wwithin International Tours, Homestudy Courses, ANTHRAX & OTHER Vaccine Dangers Education, Homeopathic Education CEU's for nurses, Books & Multi-Pure Water Filters Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.